The U.S. Food and Drug Administration today approved the first gel sealant for use in stopping fluid from leaking through the incision in a patient's cornea after cataract surgery with intraocular lens placement in adults. Prior to today's ...
Tags: Gel for Sealing Corneal Incision, First Gel After Cataract Surgery
The drugs Mekinist and Tafinlar were approved for combination treatment of advanced melanoma skin cancer, the U.S. Food and Drug Administration announced Friday. The two medicines "are the first drugs approved for combination treatment of ...
Tags: FDA, 2-Drug Combo Treatment, Combo Treatment for Advanced Melanoma
A sealant gel to prevent fluid leakage after cataract surgery has been approved by the U.S. Food and Drug Administration. While gels such as ReSure have been approved to seal small incisions in other parts of the body, this is the first ...
Tags: Sealant Gel, Eye Surgery
Farxiga (dapaglifozin) has been approved by the U.S. Food and Drug Administration to treat adults with type 2 diabetes, the agency said Wednesday in a news release. The drug, to be used for blood sugar control along with proper diet and ...
Tags: Farxiga, Type 2 Diabetes, Medicine News
When it comes to foodborne illness, fresh produce belies its healthful aura: Fresh fruits and vegetables account for 24 percent of U.S. foodborne illness in which both the responsible food and contaminant are identified, according to a 2013 ...
Tags: on-Farm Safety, Safety of Fruits, Safety of Vegetables
Sunesis Pharmaceuticals has expanded its hematology franchise through separate global licensing agreements for two preclinical kinase inhibitor programs. The first agreement, with Biogen Idec, is for global commercial rights to SNS-062, a ...
Tags: Sunesis Pharmaceuticals, Medicine
The US Food and Drug Administration (FDA) has approved GlaxoSmithKline's (GSK) use of Mekinist (trametinib) in combination with Tafinlar (dabrafenib) for the treatment of patients with unresectable melanoma or metastatic melanoma with BRAF ...
Tags: FDA, Combination Drug
Cardica, a medical device company, has received 510(k) approval from the US Food and Drug Administration (FDA) for its MicroCutter Xchange 30 device and blue staple cartridge for medium thickness tissue. The company has designed the ...
Tags: Cardica, medical device
Radius Medical has announced the US Food and Drug Administration (FDA) approval and product introduction of its new Prodigy support catheter. The company has designed the Prodigy support catheter for providing back up support to the ...
Tags: Radius Medical, Medicine
Swarms of morning commuters clutch cups of coffee to kick-start the workday. But a new study suggests caffeine might do more for the brain than boost alertness -- it may help memory too. Researchers from Johns Hopkins University looked at ...
Officials at the U.S. Food and Drug Administration say they want to hear from people if they think a tobacco product is defective or causes a health issue. The Department of Health and Human Services' Safety Reporting Portal was revised ...
A new kind of implant may offer people suffering from sleep apnea an alternative to wearing an air mask while they snooze, researchers report. With the implant, a pacemaker delivers electrical impulses to a nerve that controls the tongue ...
Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) recently approved ISENTRESS® for oral suspension, a new pediatric formulation of Merck's integrase ...
Tags: Merck, ISENTRESS®, oral suspension, pediatric formulation
Globus Medical, a musculoskeletal implant manufacturer, has announced the acquisition of Excelsius Surgical, the developer of a next generation surgical robotic positioning platform for spine, brain and therapeutic markets. The company ...
Tags: Globus Medical, Medicine
Mylan Inc. (Nasdaq: MYL) today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Mycophenolic Acid Delayed-release Tablets, 180 mg and 360 mg. This product is the generic version of Novartis' Myfortic® ...